# Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea

> **NCT06090565** · PHASE4 · COMPLETED · sponsor: **Bulovka Hospital** · enrollment: 161 (actual)

## Conditions studied

- Gonorrhea

## Interventions

- **DRUG:** Cefixime
- **DRUG:** Doxycyclin
- **DRUG:** Ceftriaxon
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT06090565
- **Lead sponsor:** Bulovka Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-12-22
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06090565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06090565, "Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06090565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*